Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immuron (IMRN) EBIT Margin (2023 - 2024)

Updated

Immuron (IMRN) posted EBIT Margin of -51.98% for FY2026 (year ended Aug 28, 2026), up 21.88 percentage points from -73.85% in FY2025.

Analysis

Immuron (IMRN) EBIT Margin (2023 - 2024) Analysis & Trends

Since FY2015, Immuron has reported EBIT Margin for 12 fiscal years.

  • Annual EBIT Margin shows a five-year change of +5696.50 percentage points (FY2021 to FY2026).
  • The FY2026 figure stands as the highest annual EBIT Margin since FY2016.
  • Business Quant data shows IMRN's EBIT Margin at -73.85% in FY2025, -118.32% in FY2024 (-32.57 pp), -85.76% in FY2023 (+237.31 pp) and -323.07% in FY2022 (+5425.42 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Immuron 7.32 Mn -9.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 9, 2024 -118.32%
Dec 31, 2023 -197.75%
API Access

Immuron EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IMRN&period=max&api_key=YOUR_API_KEY